NORCROSS, Ga., Sept. 23, 2013 (GLOBE NEWSWIRE) -- Galectin Therapeutics (Nasdaq:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that Company leadership will present at three upcoming conferences. These presentations are part of a long standing and ongoing effort to communicate the goals and progress of the Company to a broad group of biotech and general fundamental investors.
Help employers find you! Check out all the jobs and post your resume.
